WHOCC
Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

G GENITO URINARY SYSTEM AND SEX HORMONES
G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM

Other hormones, see H - Systemic hormonal preparations, excl. sex hormones and insulins.
Sex hormones used only in the treatment of neoplastic diseases (often selected strengths) are classified in L - Antineoplastic and immunomodulating agents.

The DDDs of many of the hormone preparations may vary considerably with the route of administration due to substantial differences in bioavailability. The DDDs of depot preparations are calculated as the dose divided by the dosing interval.


G03D PROGESTOGENS

This group comprises progestogens and combinations, except combinations with
- androgens, see G03E
- estrogens, see G03F
Hormonal contraceptives, see G03A
IUDs (intrauterine dervices) with progestogens, see G02BA.
Progestogens only used in neoplastic diseases, see L - Antineoplastic and immunomodulating agents.
The group is subdivided according to chemical structure.

The DDDs are based on gynecological indications, for instance corpus luteum insufficiency and endometriosis.


G03DC Estren derivatives

Tibolone is classified in G03CX.


List of abbreviations

Last updated: 2024-01-26